FDA schválil první biosimilární přípravek v USA
Authors:
E. Srbová
Authors‘ workplace:
redakce Zdravotnických novin, Praha
Published in:
Klin Onkol 2015; 28(2): 142
Category:
Oncology Highlights
Tato aktualita byla podpořena firmou Sandoz.
Overview
Submitted:
26. 3. 2015
Labels
Paediatric clinical oncology Surgery Clinical oncologyArticle was published in
Clinical Oncology
2015 Issue 2
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Metamizole in perioperative treatment in children under 14 years – results of a questionnaire survey from practice
- Metamizole vs. Tramadol in Postoperative Analgesia
- Spasmolytic Effect of Metamizole
- The Importance of Hydration in Wound Healing
-
All articles in this issue
- Glomus Tumor of the Finger – Case Report
-
Domácí parenterální výživa v onkologii
Díl 2 – Kdy indikovat domácí paliativní parenterální výživu - FDA schválil první biosimilární přípravek v USA
- Rozmanitost 18F- FDG PET obrazů pacientů s maligním melanomem
- The Importance of Early Tumor Shrinkage and Deepness of Response in Assessing the Efficacy of Systemic Anticancer Treatment with Metastatic Colorectal Cancer
- Management of Chronic and Acute Pain in Patients with Cancer Diseases
- Vitamin D During Cancer Treatment
- Potential Clinical Benefit of Therapeutic Drug Monitoring of Imatinib in Oncology
- Value of Narrow Band Imaging Endoscopy in Detection of Early Laryngeal Squamous Cell Carcinoma
- Malignant Tumors of Thyroid Gland
- Controversies in the Management of Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer
- Current Two EGFR Mutations in Lung Adenocarcinoma – Case Report
- Clinical Oncology
- Journal archive
- Current issue
- About the journal
Most read in this issue
- Malignant Tumors of Thyroid Gland
- Vitamin D During Cancer Treatment
- Glomus Tumor of the Finger – Case Report
- The Importance of Early Tumor Shrinkage and Deepness of Response in Assessing the Efficacy of Systemic Anticancer Treatment with Metastatic Colorectal Cancer